GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) financials
GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
- Market Cap: ₹755Cr.
- Current Price: ₹104
- Stock P/E: 35.0
- ROE: 22.9%
- ROCE: 27.7%
- Book Value: ₹20.5
- Dividend Yield: 0.00%
- 52W High / Low: ₹164/69.2
In Jun 2026, GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) reported sales ₹13.68 Cr and net profit ₹1.66 Cr.
Annual TTM: sales ₹73 Cr, net profit ₹22 Cr.
Shareholding: Promoters 71.29% (Jun 2026), FIIs 3.01% (Jun 2026), DIIs 2.22% (Jun 2026), Public 23.47% (Jun 2026), No. of Shareholders 21,910% (Jun 2026).
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 13.95 | 16.82 | 12.27 | 22.95 | 14.19 | 22.17 | 13.68 |
| Expenses | 8.37 | 8.54 | 8.11 | 9.67 | 8.36 | 10.91 | 11.50 |
| Operating Profit | 5.58 | 8.28 | 4.16 | 13.28 | 5.83 | 11.26 | 2.18 |
| OPM % | 40.00% | 49.23% | 33.90% | 57.86% | 41.09% | 50.79% | 15.94% |
| Other Income | 0.00 | 0.23 | 0.00 | 0.12 | 0.10 | 0.18 | 1.12 |
| Interest | 0.39 | 0.43 | 0.50 | 0.51 | 1.12 | 1.24 | 0.32 |
| Depreciation | 0.57 | 0.36 | 0.58 | 0.59 | 0.47 | 0.61 | 0.68 |
| Profit before tax | 4.62 | 7.72 | 3.08 | 12.30 | 4.34 | 9.59 | 2.30 |
| Tax % | 27.71% | 19.69% | 23.38% | 26.67% | 26.73% | 19.40% | 27.83% |
| Net Profit | 3.35 | 6.21 | 2.35 | 9.03 | 3.18 | 7.73 | 1.66 |
| EPS in Rs | 0.55 | 1.01 | 0.38 | 1.47 | 0.52 | 1.06 | 0.23 |
| Raw PDF | — | — | — | — | — | — | — |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 44 | 46 | 59 | 72 | 73 |
| Expenses | 24 | 27 | 31 | 37 | 40 |
| Operating Profit | 20 | 19 | 28 | 35 | 33 |
| OPM % | 45% | 41% | 48% | 49% | 45% |
| Other Income | 0 | 0 | 0 | 0 | 2 |
| Interest | 0 | 1 | 2 | 4 | 3 |
| Depreciation | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 18 | 16 | 25 | 29 | 29 |
| Tax % | 26% | 38% | 25% | 24% | — |
| Net Profit | 13 | 10 | 19 | 22 | 22 |
| EPS in Rs | 133.91 | 100.28 | 3.03 | 3.06 | 3.28 |
| Dividend Payout % | 48% | 0% | 0% | 0% | — |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 31 | 36 |
| Reserves | 22 | 26 | 15 | 113 |
| Borrowings | 10 | 17 | 21 | 23 |
| Other Liabilities | 2 | 7 | 9 | 7 |
| Total Liabilities | 35 | 51 | 75 | 179 |
| Fixed Assets | 16 | 18 | 18 | 15 |
| CWIP | 0 | 0 | 7 | 12 |
| Investments | 1 | 1 | 6 | 6 |
| Other Assets | 18 | 31 | 44 | 145 |
| Total Assets | 35 | 51 | 75 | 179 |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from Operating Activity | 24 | 3 | 8 | 7 |
| Cash from Investing Activity | -14 | -5 | -15 | -86 |
| Cash from Financing Activity | 4 | -1 | 2 | 80 |
| Net Cash Flow | 13 | -3 | -5 | 2 |
| Free Cash Flow | 11 | 1 | -0 | 3 |
| CFO/OP | 145% | 28% | 46% | 53% |
| Category | Mar 2026 | Jun 2026 |
|---|---|---|
| Promoters | 71.29% | 71.29% |
| FIIs | 6.70% | 3.01% |
| DIIs | 2.63% | 2.22% |
| Public | 19.39% | 23.47% |
| No. of Shareholders | 19,854 | 21,910 |
| Category | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 7 | 108 | 146 | 217 |
| Inventory Days | 101 | 141 | 170 | 177 |
| Days Payable | 83 | 85 | 114 | 217 |
| Cash Conversion Cycle | 26 | 164 | 203 | 176 |
| Working Capital Days | -54 | -22 | 46 | 124 |
| ROCE % | — | 44% | 48% | 28% |
Gaudium Ivf N Women H L
₹755Cr.
₹104
₹164/69.2
35.0
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of GAUDIUM IVF N WOMEN H L (GAUDIUMIVF)?
The reported market capitalisation for GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) is ₹755Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of GAUDIUMIVF?
The current price shown for GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) on Fincrux is ₹104 with a 52-week high/low of ₹164/69.2.
What is the P/E ratio of GAUDIUM IVF N WOMEN H L (GAUDIUMIVF)?
The stock P/E for GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) is 35.0 on Fincrux, with ROE at 22.9% and ROCE at 27.7%.
What were GAUDIUMIVF latest quarterly results?
For Jun 2026, GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) reported sales ₹13.68 Cr and net profit ₹1.66 Cr (figures in ₹ crore unless noted).
What are GAUDIUMIVF annual sales and net profit?
For TTM, GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) shows sales of ₹73 Cr and net profit of ₹22 Cr on the Fincrux profit & loss statement.
Who owns GAUDIUM IVF N WOMEN H L (GAUDIUMIVF)?
Latest shareholding for GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) on Fincrux: Promoters 71.29% (Jun 2026), FIIs 3.01% (Jun 2026), DIIs 2.22% (Jun 2026), Public 23.47% (Jun 2026), No. of Shareholders 21,910% (Jun 2026).
Where can I find GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) financials?
GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show GAUDIUMIVF balance sheet and cash flow?
Yes. The GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.